| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 22 |
| 1 | PREDNISONE | 21 |
| 2 | ACETAMINOPHEN | 19 |
| 3 | ALBUTEROL SULFATE | 19 |
| 4 | DIPHENHYDRAMINE HYDROCHLORIDE | 18 |
| 5 | LORATADINE | 17 |
| 6 | LORAZEPAM | 17 |
| 7 | MONTELUKAST SODIUM | 17 |
| 8 | CLOZAPINE | 16 |
| 9 | DIAZEPAM | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LACTULOSE SOLUTION USP, 10 G/15 ML | 1 | 0.0099 |
| 1 | BENZYL ALCOHOL | 1 | 0.0095 |
| 2 | BORON | 1 | 0.0033 |
| 3 | TOPICAL ANESTHETIC | 2 | 0.0025 |
| 4 | BENZOCAINE | 2 | 0.0020 |
| 5 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0015 |
| 6 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 1 | 0.0015 |
| 7 | AMPHETAMINE SULFATE TABLETS | 2 | 0.0012 |
| 8 | METHAMPHETAMINE HYDROCHLORIDE | 1 | 0.0009 |
| 9 | SODIUM CITRATE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 48 |
| 1 | Atypical Antipsychotic [EPC] | 30 |
| 2 | Corticosteroid [EPC] | 28 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 17 |
| 5 | Anti-IgE [EPC] | 16 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 15 |
| 7 | Estrogen [EPC] | 13 |
| 8 | Expectorant [EPC] | 12 |
| 9 | Androgen [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Androgen [EPC] | 11 | 0.0004 |
| 3 | Sigma-1 Agonist [EPC] | 3 | 0.0003 |
| 4 | Calcitonin [EPC] | 1 | 0.0003 |
| 5 | Pediculicide [EPC] | 1 | 0.0002 |
| 6 | Anti-IgE [EPC] | 16 | 0.0002 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7 | 0.0001 |
| 9 | Cannabinoid [EPC] | 1 | 0.0001 |